About Nootropics & Cognitive Enhancement
The Nootropics & Cognitive Enhancement category is part of the Longevity & Human Enhancement market map, tracking 13 companies building in this segment. Senolytics, epigenetic reprogramming, exoskeletons, nootropics, and implantable devices pushing the boundaries of human lifespan and performance. Curated by Hartmann Capital's venture research team.
Companies in Nootropics & Cognitive Enhancement
- Thesis
- Neurohacker Collective
- Nootopia
- Heights — Series A, $10M
- BrainCo — Series B, $30M
- Noowave
- Onnit — Acquired, $28M
- TruBrain — Seed, $2M
- HVMN — Series A, $20M
- Nuvana
- Neuro
- Peak — Series B, $12M
- Natrium Health
Frequently Asked Questions
- What companies are in the Nootropics & Cognitive Enhancement category?
- The Nootropics & Cognitive Enhancement category includes 13 companies: Thesis, Neurohacker Collective, Nootopia, Heights, BrainCo, Noowave, Onnit, TruBrain, HVMN, Nuvana, Neuro, Peak, Natrium Health. This is part of the Longevity & Human Enhancement market map maintained by Hartmann Capital.
- How many Nootropics & Cognitive Enhancement startups are tracked?
- Hartmann Capital tracks 13 companies in the Nootropics & Cognitive Enhancement segment of the Longevity & Human Enhancement market map.
- What are the best funded Nootropics & Cognitive Enhancement companies?
- Top funded companies in Nootropics & Cognitive Enhancement include BrainCo ($30M), Onnit ($28M), HVMN ($20M), Peak ($12M), Heights ($10M). Browse the full list in the Longevity & Human Enhancement market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.